LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 15 of 15: Calculated dose-response metrics. - Dataset (ID:20252)
Small Molecules Studied
Download: Excel (XLSX), Comma-separated (CSV), Images (Zip file)
| HMS LINCS ID | Name | Alternative Names | LINCS ID | Structure Image | PubChem CID |
|---|---|---|---|---|---|
| 10109-1 | YM 201636 | Kin001-170 | LSM-1109 |  | 9956222 |
| 10059-1 | AZD-6482 | KIN001-193 | LSM-1059 |  | 44137675 |
| 10100-1 | JNK-9L | KIN001-204 | LSM-36386 |  | 25222038 |
| 10072-1 | PF562271 | KIN001-205 | LSM-1072 |  | 11713159 |
| 10017-1 | HG-6-64-01 | KIN001-206 | LSM-43248 |  | |
| 10158-1 | AZD 5438 | KIN001-239 | LSM-1159 |  | 16747683 |
| 10061-1 | NU7441 | KU 57788 | LSM-1061 |  | 11327430 |
| 10086-1 | XMD11-50 | LRRK2-in-1 | LSM-1086 |  | 46843906 |
| 10069-1 | Enzastaurin | LY317615 | LSM-1069 |  | 176167 |
| 10025-1 | CGP60474 | MLS000911536; SMR000463552 | LSM-1025 |  | 644215 |
| 10480-1 | Radicicol | Monorden | LSM-43318 |  | 6323491 |
| 10041-1 | BI-2536 | NPK33-1-98-1 | LSM-1041 |  | 11364421 |
| 10481-1 | Withaferin A | NSC 273757; NSC-101088 | LSM-6685 |  | 265237 |
| 10161-1 | Luminespib | NVP-AUY922 | LSM-1162 |  | 53401173 |
| 10097-1 | Erlotinib | OSI-774 | LSM-1097 |  | 176870 |
| 10135-1 | Linsitinib | OSI 906 | LSM-1135 |  | 11640390 |
| 10071-1 | Palbociclib | PD0332991 | LSM-1071 |  | 5330286 |
| 10101-1 | PD0325901 | PD-325901 | LSM-1101 |  | 9826528 |
| 10027-1 | Crizotinib | PF02341066 | LSM-1027 |  | 11626560 |
| 10047-1 | Pictilisib | Pictrelisib; GDC-0941; RG-7321 | LSM-1047 |  | 17755052 |
| 10119-1 | SU11274 | PKI-SU11274 | LSM-42791 |  | 53396327 |
| 10068-1 | Vemurafenib | PLX4032; RG7204; R7204; RO5185426 | LSM-1068 |  | 42611257 |
| 10052-1 | Sirolimus | Rapamycin | LSM-1052 |  | 5040 |
| 10234-1 | GDC-0980 | RG7422 | LSM-4257 |  | 66694608 |
| 10001-1 | Seliciclib | (R)-Roscovitine; CYC202 | LSM-1001 |  | 160355 |